Signet Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.09M Sell
3,983
-20
-0.5% -$10.5K 0.26% 120
2025
Q1
$2.54M Buy
4,003
+83
+2% +$52.6K 0.34% 97
2024
Q4
$2.79M Sell
3,920
-110
-3% -$78.4K 0.36% 88
2024
Q3
$4.24M Buy
4,030
+5
+0.1% +$5.26K 0.54% 56
2024
Q2
$4.23M Buy
4,025
+5
+0.1% +$5.26K 0.57% 50
2024
Q1
$3.87M Buy
4,020
+78
+2% +$75.1K 0.53% 60
2023
Q4
$3.46M Sell
3,942
-1
-0% -$878 0.52% 61
2023
Q3
$3.25M Sell
3,943
-46
-1% -$37.9K 0.54% 60
2023
Q2
$2.87M Buy
3,989
+24
+0.6% +$17.2K 0.45% 71
2023
Q1
$3.26M Buy
3,965
+11
+0.3% +$9.04K 0.55% 58
2022
Q4
$2.85M Sell
3,954
-33
-0.8% -$23.8K 0.51% 64
2022
Q3
$2.75M Buy
3,987
+20
+0.5% +$13.8K 0.54% 53
2022
Q2
$2.35M Hold
3,967
0.45% 65
2022
Q1
$2.77M Buy
3,967
+51
+1% +$35.6K 0.46% 62
2021
Q4
$2.47M Buy
3,916
+42
+1% +$26.5K 0.37% 70
2021
Q3
$2.35M Buy
3,874
+11
+0.3% +$6.66K 0.4% 71
2021
Q2
$2.16M Sell
3,863
-4
-0.1% -$2.24K 0.74% 33
2021
Q1
$1.83M Sell
3,867
-129
-3% -$61K 0.34% 86
2020
Q4
$1.93M Sell
3,996
-107
-3% -$51.7K 0.39% 78
2020
Q3
$2.41M Sell
4,103
-200
-5% -$117K 0.53% 55
2020
Q2
$2.62M Sell
4,303
-495
-10% -$301K 0.58% 54
2020
Q1
$2.68M Sell
4,798
-605
-11% -$337K 0.63% 52
2019
Q4
$2.03M Sell
5,403
-113
-2% -$42.4K 0.38% 84
2019
Q3
$1.9M Sell
5,516
-355
-6% -$122K 0.37% 86
2019
Q2
$1.82M Sell
5,871
-785
-12% -$243K 0.36% 88
2019
Q1
$2.23M Sell
6,656
-248
-4% -$83.2K 0.44% 80
2018
Q4
$2.58M Buy
6,904
+6,475
+1,509% +$2.42M 0.56% 69
2018
Q3
$173K Buy
429
+28
+7% +$11.3K 0.03% 239
2018
Q2
$138K Buy
+401
New +$138K 0.02% 270